repository
BROWSE
Cited 0 times in 
Pharmaceutical composition for preventing or treating SNCG overexpression disease comprising an PD-184352 as an active ingredient
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 양시영 | - |
| dc.date.accessioned | 2023-05-26T01:13:33Z | - |
| dc.date.available | 2023-05-26T01:13:33Z | - |
| dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/25738 | - |
| dc.description.abstract | 본 발명은 SNCG(Synuclein Gamma) 억제제인 PD-184352는 SNCG(Synuclein Gamma) 단백질의 C-말단에 결합하여 SNCG에 의해 조절되는 퇴행성 질환과 관련 인자들인 MMP3, MMP13 및 COX2의 발현을 억제하는 것을 확인함으로써, 상기 화합물은 SNCG에 의해 발병되는 퇴행성 관절염 및 파킨슨병의 치료제로 제공된다. | - |
| dc.language.iso | ko | - |
| dc.title | Pharmaceutical composition for preventing or treating SNCG overexpression disease comprising an PD-184352 as an active ingredient | - |
| dc.title.alternative | PD-184352를 유효성분으로 포함하는 SNCG 과발현 질환의 예방 또는 치료용 약학적 조성물 | - |
| dc.type | Patent | - |
| dc.contributor.affiliatedAuthor | 양시영 | - |
| dc.date.application | 2021-07-30 | - |
| dc.type.local | Patents | - |
| dc.identifier.doi | 10.8080/1020210100767 | - |
| dc.identifier.patentApplicationNumber | 1020210100767 | - |
| dc.embargo.liftdate | 9999-12-31 | - |
| dc.embargo.terms | 9999-12-31 | - |
- Appears in Collections:
- Patents > School of Medicine / Graduate School of Medicine > Pharmacology
- Files in This Item:
- There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
-
- License
